A comprehensive view of Zimmer Biomet Holdings Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
BTIG expects medtech sector to rebound in 2024, noting easing inflation and hospital staffing issues after 2023's choppy supply-chain dynamics, fears about impact of GLP-1 drugs; Zimmer Biomet, Abbott Laboratories, Glaukos, iRhythm expected to outperform
Published:
December 20, 2023
by MedTech Dive
|
3M’s Health Care Business Group appoints Bryan Hanson as CEO effective September 1 when the new company spins off from 3M; Hanson joins 3M from Zimmer Biomet, where he served as President, CEO and Chairman
Published:
August 22, 2023
by 3M Co.
|
Ask us about our Transformation & Innovation market view